Clinical Study of BYM338 for the Treatment of Unintentional Weight Loss in Patients With Cancer of the Lung or the Pancreas
Clinical trial NCT01433263 · COMPLETED
Trial details
- NCT number
- NCT01433263
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-01
- Primary completion
- 2014-04-01
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.